Saturday, July 11, 2026

pharma · Restless Legs Syndrome

Dong Jie

Dong Jie clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Dong Jie projects

1 ClinicalTrials.gov programs sponsored by Dong Jie.

Dong Jie has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Pramipexole

    Dong Jie

    Restless Legs Syndrome

    approved small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does Dong Jie have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.